Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Review
  • Published:

A review of European guidelines on periconceptional folic acid supplementation

European Journal of Clinical Nutrition volume 70, pages 143–154 (2016)Cite this article

Subjects

Abstract

Strong evidence that folic acid (FA) prevents the majority of cases of neural tube defects (NTDs) has led to national organisations developing guidelines for women concerning periconceptional supplementation. In Europe, there is evidence of national variations in the incidence of NTDs, with a recent Irish study reporting an increase in the rate. This review compares the periconceptional FA supplementation guidelines between the different countries in Europe. An online search of country-specific guidelines produced before 2015 concerning periconceptional FA supplementation was conducted. If an English version was not available directly, the EUROCAT register was searched for the English version of the recommendations. We identified national guidelines from 20 European countries. Over half recommended that FA supplements be taken by women planning a pregnancy, but three recommended that they should be taken by all women of child-bearing age. Four guidelines recommended starting FA at least 4 weeks preconceptionally, but no country recommended starting FA at least 12 weeks preconceptionally as suggested by recently published studies. There is a need for further consideration of the duration of preconceptional FA supplementation specifically. The latest scientific evidence in this area should inform the development of European guidelines on FA, as there is wide variation in current recommendations. Overall, the wide variation in national guidelines concerning periconceptional FA supplementation may in part explain the differences in national rates of NTDs reported by EUROCAT. National guidelines on FA supplementation should be standardised across European countries.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Copp AJ, Stanier P, Greene ND . Neural tube defects – recent advances, unsolved questions and controversies. Lancet Neurol 2013; 12: 799–810.

    Article  Google Scholar 

  2. Yi Y, Lindemann M, Colligs A, Snowball C . Economic burden of neural tube defects and impact of prevention with folic acid: a literature review. Eur J Pediatr 2011; 170: 1391–1400.

    Article  Google Scholar 

  3. Medical Research Council Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council Vitamin Study. Lancet 1991; 338: 131–137.

    Article  Google Scholar 

  4. Czeizel A, Dudas I . Prevention of the first occurrences of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992; 327: 1832–1835.

    Article  CAS  Google Scholar 

  5. Botto LD, Lisi A, Robert-Gnansia E, Erickson JD, Vollset SE, Mastroiacovo P et al. International retrospective cohort study of neural tube defects in relation to folic acid recommendations: are the recommendations working? BMJ 2005; 330: 571.

    Article  Google Scholar 

  6. Mc Donnell R, Delaney V, O’Mahony MT, Mullaney C, Lee B, Turner MJ . Neural tube defects in the Republic of Ireland in 2009-11. J Public Health 2014; 37: 57–63.

    Article  Google Scholar 

  7. Lamers Y, Prinz-Langenohl R, Bramswig S, Pietrzik K . Red blood cell folate concentrations increase more after supplementation with [6S]-5methyl tetrahydrafolae than with folic acid in women of childbearing age. Am J Clin Nutr 2006; 84: 156–161.

    Article  CAS  Google Scholar 

  8. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R et al. Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child 1981; 56: 911–918.

    Article  CAS  Google Scholar 

  9. Molloy AM, Kirke PN, Troendle JF, Burke H, Sutton M, Brody LC et al. Maternal vitamin B12 status and risk of neural tube defects in a population with high neural tube defect prevalence and no folic Acid fortification. Pediatrics 2009; 123: 917–923.

    Article  Google Scholar 

  10. Crider KS, Devine O, Hao L, Dowling NF, Li S, Molloy AM et al. Population of red blood cell folate concentration for prevention of neural tube defects: Bayesian model. BMJ 2014; 349: g4554.

    Article  Google Scholar 

  11. Norsworthy B, Skeaff CM, Adank C, Green TJ . Effects of once-a-week or daily folic acid supplementation on red blood cell folate concentrations in women. Eur J Clin Nutr 2004; 58: 548–554.

    Article  CAS  Google Scholar 

  12. Hurthouse NA, Gray AR, Miller JC, Rose MC, Houghton LA . Folate status of reproductive age women and neural tube defect risk- the effect of long term folic acid supplementation at doses of 140 μg and 400 μg per day. Nutrients 2011; 3: 49–62.

    Article  Google Scholar 

  13. McNulty B, Pentieva K, Marshall B, Ward M, Molloy AM, Scott JM et al. Women's compliance with current folic acid recommendations and achievement of optimal vitamin status for preventing neural tube defects. Hum Reprod. 2011; 2: 1530–1536.

    Article  Google Scholar 

  14. Pollak A, Gruber W, Birnbacher R, Zwiauer K . Richtlinien zur Praevention von Neuralrohredefekten durch perikonzeptionelle Folsaeuresubstitution. Gynaekologisch-geburtshilfliche Rundschau 1998; 38: 55–56.

    Article  Google Scholar 

  15. EUROCAT Special Report: Prevention of Neural Tube Defects by Periconpceptional Folic Acid Supplementation in Europe - December 2009 – Country Specific Chapters – Report on periconceptional supplementation for Belgium. [Online] Available http://www.eurocat-network.eu/content/NTD-Dec2007-Belgium.pdf (accessed April 2015).

  16. EUROCAT Special Report: Prevention of Neural Tube Defects by Periconpceptional Folic Acid Supplementation in Europe - December 2009 – Country Specific Chapters – Report on periconceptional supplementation for Croatia. [Online] Available http://www.eurocat-network.eu/content/NTD-Dec2007-Croatia.pdf (accessed April 2015).

  17. Rasmussen LB, Andersen NL, Andersson G, Lange AP, Rasmussen K, Skak-Iversen L et al. Folate and neural tube defects: Recommendations from a Danish working group. Dan Med Bull 1998; 45: 213–217.

    CAS  PubMed  Google Scholar 

  18. Sosiaali- ja terveysministerion asiantuntijaryhma. Hoitosuositus. Foolihappo ja hermostoputken sulkeutumishäiriöt 1995, 33/623/95.

  19. Stakes (1999). Seulontatutkimukset jayhteistyö äitiyshuollossa. Suositukset Oppaita 34. Viisainen K (toim). Helsinki.

  20. Hasunen K, Kalavainen M, Keinonen H, Lagström H, Lyytikäinen A, Nurttila A et al. The Child, Family and Food. Nutrition recommendations for infants and young children as well as pregnant and breastfeeding mothers. Publications of the Ministry of Social Affairs and Health Helsinki 2004; 11.

  21. EUROCAT Special Report: Prevention of Neural Tube Defects by Periconpceptional Folic Acid Supplementation in Europe - December 2009 – Country Specific Chapters – Report on periconceptional supplementation for France. [Online] Available http://www.eurocat-network.eu/content/NTD-Dec2007-France.pdf.

  22. Dehé S, Vodovar V, Vérité V, Goujard J . Prevention primaire des anomalies de fermeture du tube neural par supplementation periconceptionnelle en acide folique. Situation à Paris en 1999 (Primary prevention of neural tube defects by supplementation in folic acid. 1999 status in Paris)'. BEH 2000; 21: 87–89.

    Google Scholar 

  23. Koletzko B, von Kries R . Prävention von Neural rohrdefekten durch Folsäurezufuhr in der Frühschwangerschaft. Der Frauenarzt 1994; 35: 1007–1010.

    Google Scholar 

  24. Koletzko B, von Kries R . Prävention von Neural rohrdefekten durch Folsäurezufuhr in der Frühschwangerschaft. Der Kinderarzt 1995; 26: 187–190.

    Google Scholar 

  25. Deutsche Gesellschaft für Ernährung (DGE) 2000. Ernährungsbericht 2000. Bonn.

  26. EUROCAT Special Report: Prevention of Neural Tube Defects by Periconpceptional Folic Acid Supplementation in Europe - December 2009 – Country Specific Chapters – Report on periconceptional supplementation for Hungary. [Online] Available http://www.eurocat-network.eu/content/NTD-Dec2007-Hungary.pdf (accessed 26 August 2015).

  27. Szülészeti és Nőgyógyászati Szakmai Kollégium (National Board of Hungarian Gynaecologists). Szakmai állásfoglalás a terhesség alatti vitamin és ásványi anyag supplementatio kérdéséről (Guideline for vitamin and mineral supplementation during pregnancy). Magyar Nőorvosok Lapja 1999; 62: 63–65.

    Google Scholar 

  28. Department of Health, Republic of Ireland. Folic Acid and the Prevention of Neural Tube Defects. Department of Health Publications Unit: Dublin, 1992.

  29. Health Education Authority Ireland. Folic Acid and the Prevention of Neural Tube Defects – A Summary Guide for Health Professionals. Department of Health Library and Information’s Unit: Dublin, 1996.

  30. Food Safety Authority of Ireland. The Value of FA in Prevention of Neural Tube Defects. Department of Health Library and Information's Unit: Dublin, 1997.

  31. Institute of Obstetrics and Gynaecologists, Royal College of Physicians of Ireland and Clinical Strategy and Programmes Directorate. Health Service Executive. Obesity and pregnancy – Clinical Practice Guideline. Health Service Executive: Dublin, 2011.

  32. Acido Folico. Prove di efficacia e considerazioni utili per la riduzione del rischio di malformzioni congenite. Bolletino d’informazione sui farmaci. XI 2 2004.

  33. Department of Public Health Malta. Department of Health Circular No 36/94. Circular regarding folic acid issued to all medical practitioners 1994.

  34. Gatt M, Periconceptional Folic Acid Supplementation in Malta, in 'Half Yearly Report of Malta Congenital Anomalies Register July – December 1999, Malta Congenital Anomalies Registry, Department of Health Information. 2000 [Online] Available http://www.sahha.gov.mt/showdoc.aspx?id=43&filesource=4&file=hyjuly-dec1999.pdf) (accessed April 2015).

  35. Gezondheidsraad/ Voedingsraad (1993). Continued advice concerning folic acid use in relation to neural tube defects. [Vervolgadvies inzake foliumzuurvoorziening in relatie tot neuraalbuisdefecten.]. Den Haag, Voorlichtingsbureau van de Voeding.

  36. Statens helsetilsyn (Norweigan Board of Health) (1993). Tiltak som kan redusere forekomst av nevralrørsdefekter. Rundskriv IK-4/93.

  37. Statens råd for ernæring og fysisk aktivitet (National Council on Nutrition and Physical Activity)spring 1998, Available at http://www.sef.no/ (accessed 26 August 2015).

  38. Brzeziński Z . Primary prevention program for neural tube defects in Poland. Med Wieku Rozwoj 1999; 3: 503–508.

    PubMed  Google Scholar 

  39. Directorate General of Health, Maternal, Child and Adolescence Division (1998). Preconceptional health care, 02/DSMIA.

  40. Directorate General of Health, Maternal, Child and Adolescence Division (2006). Preconceptional health care, 02/DSMIA.

  41. Special Report: Prevention of Neural Tube Defects by Periconpceptional Folic Acid Supplementation in Europe - December 2009 – Country Specific Chapters – Report on periconceptional supplementation for Slovenia. [Online] Available http://www.eurocat-network.eu/content/NTD-Dec2007-Slovenia.pdf (accessed April 2015).

  42. Grupo Institucional (2003). Ministerio de Educación y Cultura y Ministerio de Interior. Nutrición Saludable y Prevención de los Trastornos Alimentarios. Available from http://www.msssi.gob.es/ (accessed April 2015).

  43. Dirección de Salud Pública, Ministerio de Sanidad y Consumo. Recomendaciones sobre suplementación con ácido fólico para la prevención de defectos del tubo neural. Inf Ter Sist Nac Salud 2001; 25: 66–67.

    Google Scholar 

  44. National Board of Health and Welfare 1996. Aktuellt i folsyra frågan. http://www.socialstyrelsen.se/ (accessed 26 August 2015).

  45. National Board of Health and Welfare 2001. Folsyra I Samband medgraviditet. http://www.socialstyrelsen.se/ (accessed 26 August 2015).

  46. Tönz O, Lüthy J . Folsäure zur primären Verhütung von Neuralrohrdefekten. Bulletin des Médecins Suisses 1996; 77: 569–57.

    Google Scholar 

  47. Baerlocher K, Eichholzer M, Lühy J, Moser U, Tönz O . Acide folique: Rapport d'experts de la commission fédérale d'alimentation sur la prophylaxie des anomalies du tube neural. Office fédéral de la santé publique, Berne 2002, p73.

  48. Department of Health (1992). Folic Acid and the Prevention of Neural Tube Defect: Report from an Expert Advisory Group. Department of Health Publication Unit: Heywood.

  49. National Institute for Health and Care Excellence 2008. Maternal and Child Nutrition. [Online] Available https://www.nice.org.uk/guidance/ph11/resources/guidance-maternal-and-child-nutrition-pdf (accessed 26 August 2015).

  50. National Health Services 2013. Vitamins and Nutrition in pregnancy. [Online] Available http://www.nhs.uk/conditions/pregnancy-and-baby/pages/vitamins-minerals-supplements-pregnant.aspx#close (accessed 26 August 2015).

  51. National Health Service Scotland 2011. Folic acid: Before and during pregnancy. [Online] Available http://www.healthscotland.com/uploads/documents/20011-FolicAcidCard.pdf (accessed 26 August 2015).

  52. Stamm RA, Houghton CA . Nutrient intake values for folate during pregnancy and lactation vary widely around the world. Nutrients 2013; 5: 3920–3947.

    Article  CAS  Google Scholar 

  53. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM . Maternal plasma folate and vitamin B12 are independent risk factors for NTDs. Quarterly J Med 1993; 86: 703–708.

    CAS  Google Scholar 

  54. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H et al. Prevention of neural tube defects with FA in China.-Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999; 341: 1485–1490.

    Article  CAS  Google Scholar 

  55. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM . Folate levels and neural tube defects: Implication for prevention. JAMA 1995; 274: 1698–1702.

    Article  CAS  Google Scholar 

  56. Health Canada 2013. Prenatal Nutrition Guidelines for Health Professionals Folate Contributes to a Healthy Pregnancy. [Online] Available http://www.hc-sc.gc.ca/fn-an/alt_formats/hpfb-dgpsa/pdf/pubs/folate-eng.pdf (accessed 26 August 2015).

  57. Australian Government – Department of Health and Ageing 2012. Clinical Practice Guidelines Antenatal Care - Module 1. Commonwealth of Australia.

  58. Moreau C, Bohet A, Le Guen M, Loilier AR, Bajos N . FECOND Group. Unplanned or unwanted? A randomized study of national estimates of pregnancy intentions. Fertil Steril 2014; 102: 1663–1670.

    Article  Google Scholar 

  59. Grosse SD, Collins JS . Folic acid supplementation and neural tube defect recurrence prevention. Br Med J (Clin Res Ed) 1981; 282: 1509–1511.

    Article  Google Scholar 

  60. Laurence KM, James N, Miller MH, Tennant GB, Campbell H . Double-blind randomised controlled trial of folate treatment before conception to prevent recurrence of neural-tube defects. Birth Defects Res A Clin Mol Teratol 2007; 79: 737–742.

    Article  Google Scholar 

  61. Indian Council of Medical Research. Multicentre study of efficacy of periconceptional folic acid containing vitamin supplementation in prevention of open neural tube defects from India. Indian J Med Res 2000; 112: 206–221.

    Google Scholar 

  62. Kelly F, Gibney FR, Boilson A, Staines A, Sweeney MR . Folic acid levels in some food staples in Ireland are on the decline: implications for passive folic acid intake. J Public Health e-pub ahead of print 8 March 2015; doi:doi:10.1093/pubmed/fdv025.

Download references

Author information

Authors and Affiliations

  1. School of Biological Sciences, Dublin Institute of Technology, Dublin 8, Ireland

    S Cawley, L Mullaney & D McCartney

  2. UCD Centre for Human Reproduction, Coombe Women and Infants University Hospital, Dublin 8, Ireland

    A McKeating, M Farren & M J Turner

Authors
  1. S Cawley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L Mullaney
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A McKeating
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M Farren
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D McCartney
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M J Turner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Cawley.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cawley, S., Mullaney, L., McKeating, A. et al. A review of European guidelines on periconceptional folic acid supplementation. Eur J Clin Nutr 70, 143–154 (2016). https://doi.org/10.1038/ejcn.2015.131

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ejcn.2015.131

This article is cited by

Search

Advanced search

Quick links